Intellipharmaceutics International (IPCIF) News Today Add Compare Share Share Headlines Stock AnalysisChartSEC FilingsBuy This Stock IPCIF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Cease Trade OrderMarch 6, 2024 | finanznachrichten.deIntellipharmaceutics International Inc. (IPCI.TO)February 28, 2024 | ca.finance.yahoo.comIntellipharmaceutics International Inc. Announces Stock Option GrantFebruary 8, 2024 | finance.yahoo.comIntellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture ExchangeJanuary 2, 2024 | finance.yahoo.comIntellipharmaceutics International Inc.: Intellipharmaceutics Announces Third Quarter 2023 ResultsOctober 16, 2023 | finanznachrichten.deIntellipharmaceutics Announces Second Quarter 2023 ResultsJuly 14, 2023 | finance.yahoo.comClosing Bell: Intellipharmaceutics International Inc up on Monday (IPCI)June 27, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc up on Friday (IPCI)June 10, 2023 | theglobeandmail.comIntellipharmaceutics International reports FY 2022 and Q1 2023 resultsJune 6, 2023 | msn.comIntellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 ResultsJune 6, 2023 | finance.yahoo.comJim Cramer -- International Paper, United Technologies Looking More AttractiveMay 10, 2023 | thestreet.comClosing Bell: Intellipharmaceutics International Inc flat on Tuesday (IPCI)April 12, 2023 | theglobeandmail.comClosing Bell: Intellipharmaceutics International Inc flat on Thursday (IPCI)April 11, 2023 | theglobeandmail.comIPCIF Intellipharmaceutics International Inc.March 17, 2023 | seekingalpha.comIntellipharmaceutics Announces Cease Trade OrderMarch 7, 2023 | finance.yahoo.comIntellipharmaceutics Announces its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form and its Management Cease Trade Order ApplicationFebruary 6, 2023 | finance.yahoo.comIntellipharmaceutics International Inc.: Intellipharmaceutics Announces Third Quarter 2022 ResultsOctober 15, 2022 | finanznachrichten.deIntellipharmaceutics Announces Third Quarter 2022 ResultsOctober 14, 2022 | finance.yahoo.comIntellipharmaceutics Announces Delay in Filing Second Quarter Results Due July 15, 2022, The Financial Statements Will be Filed By July 21, 2022July 15, 2022 | finance.yahoo.comIntellipharmaceutics Announces Fiscal Year 2021 ResultsFebruary 28, 2022 | finance.yahoo.comIntellipharmaceutics Mourns the Death of Valued Board Member Kenneth Eugene KeirsteadJanuary 13, 2022 | finance.yahoo.comIntellipharmaceutics Comments on Recent Trading ActivityDecember 22, 2021 | finance.yahoo.comIntellipharmaceutics International Inc.: Intellipharmaceutics Announces Third Quarter 2021 ResultsOctober 16, 2021 | finanznachrichten.deKim Spencer McPhee Barristers, P.C. Publishes This Notice of Settlement Approval of the Intellipharmaceutics International Inc. Securities Class ActionOctober 13, 2021 | businesswire.com Get Intellipharmaceutics International News Delivered to You Automatically Sign up to receive the latest news and ratings for IPCIF and its competitors with MarketBeat's FREE daily newsletter. Email Address IPCIF Media Mentions By Week IPCIF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPCIF News Sentiment▼0.000.50▲Average Medical News Sentiment IPCIF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPCIF Articles This Week▼00▲IPCIF Articles Average Week Get Intellipharmaceutics International News Delivered to You Automatically Sign up to receive the latest news and ratings for IPCIF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PASG News Today RVPH News Today RLMD News Today OTLC News Today PULM News Today PMN News Today CMMB News Today ATNF News Today EQ News Today IMNN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IPCIF) was last updated on 8/10/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellipharmaceutics International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intellipharmaceutics International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IPCIF Stock Alerts